VASCULAR TARGETING SYSTEM VTS, created in 2008 (Israel), from 6 sister brands and 2214 competing brands. The VASCULAR TARGETING SYSTEM VTS brand is owned by NOTABLE LABS, LTD., a company listed in New York. The International Securities Identification Number (ISIN) of NOTABLE LABS, LTD. is IL0011327454. The sector of VASCULAR TARGETING SYSTEM VTS is Biotechnology.

VASCULAR TARGETING SYSTEM VTS is a brand of NOTABLE LABS, LTD. (NTBL) Share price

Share price and profitability of the share NOTABLE LABS, LTD. (VASCULAR TARGETING SYSTEM VTS)

Buy NOTABLE LABS, LTD. share with
(0% commission and fractional shares)
Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 1.68

Portfolio valuation
NOTABLE LABS, LTD. (VASCULAR TARGETING SYSTEM VTS) over 5 years* USD 0.00

Stock market history NOTABLE LABS, LTD. (VASCULAR TARGETING SYSTEM VTS)

Desirable brands that generate Pricing Power and therefore stock market performance

Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.

Read more